Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1961 Dec;17(3):358–371. doi: 10.1111/j.1476-5381.1961.tb01122.x

Studies on a new intramuscular haematinic, iron-sorbitol

S Lindvall, N S E Andersson
PMCID: PMC1482102  PMID: 14465561

Abstract

A new iron preparation for intramuscular use is described. It contains a complex of iron, sorbitol and citric acid. Its properties in comparison with several other complexes, particularly iron-dextran, have been studied. The preparation is stable in serum, is hypertonic, does not produce haemolysis, and affects coagulation only at very high concentrations, such as are reached only in vitro. Absorption from muscle takes place very rapidly; two-thirds of the iron is removed within 3 hr, and there is a very rapid increase in the serum-iron concentration. In experimental animals, the maximum level is reached after about 20 min and in man after about 2 hr. Disappearance from the serum takes place rapidly. The preparation contains a small amount of a fraction which reacts with transferrin and is dialysable. In man, about 30% of the total dose of iron is excreted through the kidneys during the first 24 hr after injection, the greater part of the excretion taking place during the first few hours.

Full text

PDF
358

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSSON N. S. Intramuskulär järnbehandling. Sven Lakartidn. 1956 Jan 5;53(1):13–16. [PubMed] [Google Scholar]
  2. BAIRD I. M., PODMORE D. A. Intramuscular iron therapy in iron-deficiency anaemia. Lancet. 1954 Nov 6;267(6845):942–946. doi: 10.1016/s0140-6736(54)92555-6. [DOI] [PubMed] [Google Scholar]
  3. BERESFORD C. R., GOLBERG L., SMITH J. P. Local effects and mechanism of absorption of iron preparations administered intramuscularly. Br J Pharmacol Chemother. 1957 Mar;12(1):107–114. doi: 10.1111/j.1476-5381.1957.tb01371.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CAPPELL D. F., HUTCHISON H. E., HENDRY E. B., CONWAY H. A new carbohydrate-iron haematinic for intramuscular use. Br Med J. 1954 Nov 27;2(4899):1255–1257. doi: 10.1136/bmj.2.4899.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cartwright G. E., Wintrobe M. M. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIX. THE ANEMIA OF INFECTION. STUDIES ON THE IRON-BINDING CAPACITY OF SERUM. J Clin Invest. 1949 Jan;28(1):86–98. doi: 10.1172/JCI102058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GRIMES A. J., HUTT M. S. Metabolism of 59Fe-dextran complex in human subjects. Br Med J. 1957 Nov 9;2(5053):1074–1077. doi: 10.1136/bmj.2.5053.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HERNDON J. F., RICE E. G., TUCKER R. G., VAN LOON E. J., GREENBERG S. M. Iron absorption and metabolism. III. The enhancement of iron absorption in rats by D-sorbitol. J Nutr. 1958 Apr 10;64(4):615–623. doi: 10.1093/jn/64.4.615. [DOI] [PubMed] [Google Scholar]
  8. JENNISON R. F., ELLIS H. R. Intramuscular iron: a clinical trial in pregnancy. Lancet. 1954 Dec 18;267(6851):1245–1249. doi: 10.1016/s0140-6736(54)92045-0. [DOI] [PubMed] [Google Scholar]
  9. KARLEFORS T., NORDEN A. Studies on iron-dextran complex. Acta Med Scand Suppl. 1958;342:1–54. [PubMed] [Google Scholar]
  10. MARTIN L. E., BATES C. M., BERESFORD C. R., DONALDSON J. D., MCDONALD F. F., DUNLOP D., SHEARD P., LONDON E., TWIGG G. D. The pharmacology of an iron-dextran intramuscular haematinic. Br J Pharmacol Chemother. 1955 Sep;10(3):375–382. doi: 10.1111/j.1476-5381.1955.tb00887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. NISSIM J. A. Plasma iron levels and urinary iron excretion after the intravenous administration of different iron preparations. Br J Pharmacol Chemother. 1953 Dec;8(4):371–377. doi: 10.1111/j.1476-5381.1953.tb01332.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. NISSIM J. A. The mechanisms of toxicity of some iron preparations. Br J Pharmacol Chemother. 1954 Mar;9(1):103–105. doi: 10.1111/j.1476-5381.1954.tb00825.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SCOTT J. M., GOVAN A. D. T. Anaemia of pregnancy treated with intramuscular iron. Br Med J. 1954 Nov 27;2(4899):1257–1259. doi: 10.1136/bmj.2.4899.1257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SEVEN M. J., PETERSON R. E. Studies on in vivo stability of an iron chelate. Proc Soc Exp Biol Med. 1958 Feb;97(2):382–384. doi: 10.3181/00379727-97-23749. [DOI] [PubMed] [Google Scholar]
  15. SVARD P. O., LINDVALL S. Mechanism of absorption of two intramuscular iron preparation. J Pharm Pharmacol. 1961 Nov;13:650–653. doi: 10.1111/j.2042-7158.1961.tb11887.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES